RESULTS FROM A PHASE I/II TRIAL OF TINOSTAMUSTINE MONOTHERAPY IN ADVANCED SOLID TUMOURS (NCT03345485): SAFETY AND EFFICACY IN A SUBSET OF PATIENTS WITH ADVANCED OVARIAN CANCER (OVCA)

被引：0
|
作者：
Tinker, Anna V. [1 ]
Chugh, Rashmi [2 ]
Curigliano, Giuseppe [3 ]
Kummar, Shivaani [4 ]
Schneider, Reva [5 ]
Strauss, James [5 ]
Janik, Tomas [6 ]
Manamley, Nick [6 ]
Hilgier, Kasia [6 ]
Oaknin, Ana [7 ]
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[3] European Inst Oncol, IRCCS, Milan, Italy
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Mary Crowley Canc Res, Dallas, TX USA
[6] Mundipharma Res Ltd, Cambridge, England
[7] Hosp Univ Vall Hebron, Gynaecol Canc Programme, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
163
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [1] Results from a phase I/II trial of tinostamustine monotherapy in advanced solid tumours (NCT03345485): Safety and efficacy in a subset of patients (pts) with soft tissue sarcoma (STS)
    Chugh, R.
    Kummar, S.
    Schneider, R. E.
    Janik, T.
    Manamley, N.
    Hilgier, K.
    Strauss, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1048 - S1048
  • [2] A phase II study of tinostamustine in patients (pts) with advanced solid tumours
    Tinker, Anna
    Strauss, James Fredric
    Schneider, Reva
    Chugh, Rashmi
    Curigliano, Giuseppe
    Di Nicola, Massimo A.
    Oaknin, Ana
    Janik, Tomas
    Hilgier, Kasia
    Manamley, Nick
    Kummar, Shivaani
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] A phase I study of tinostamustine in patients (pts) with advanced solid tumours
    Mita, A.
    Loeffler, M.
    Bui, N.
    Remmy, D.
    Mehrling, T.
    Mita, M.
    Rimel, B. J.
    Natale, R. B.
    Kummar, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 177 - +
  • [4] Results from the Cohort Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Haematological Malignancies (NCT02576496): Findings from a Subset of Patients with Cutaneous T-Cell Lymphoma (CTCL)
    Zinzani, Pier Luigi
    Morschhauser, Franck
    Janik, Tomas
    Manamley, Nick
    Hilgier, Kasia
    Balari, Anna Maria Sureda
    BLOOD, 2023, 142
  • [5] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Yuan, Peng
    Shentu, Jianzhong
    Xu, Jianming
    Burke, Wendy
    Hsu, Kate
    Learoyd, Maria
    Zhu, Min
    Xu, Binghe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 963 - 974
  • [6] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Peng Yuan
    Jianzhong Shentu
    Jianming Xu
    Wendy Burke
    Kate Hsu
    Maria Learoyd
    Min Zhu
    Binghe Xu
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 963 - 974
  • [7] Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours
    Awada, Ahmad
    Hendlisz, Alain
    Christensen, Olaf
    Lathia, Chetan D.
    Bartholomeus, Sylvie
    Lebrun, Fabienne
    de Valeriola, Dominique
    Brendel, Erich
    Radtke, Martin
    Delaunoit, Thierry
    Piccart-Gebhart, Martine
    Gil, Thierry
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) : 465 - 474
  • [8] Phase I trial outcomes in older patients with advanced solid tumours
    Khan, K. H.
    Yap, T. A.
    Ring, A.
    Molife, L. R.
    Bodla, S.
    Thomas, K.
    Zivi, A.
    Smith, A.
    Judson, I.
    Banerji, U.
    de Bono, J. S.
    Kaye, S. B.
    BRITISH JOURNAL OF CANCER, 2016, 114 (03) : 262 - 268
  • [9] Phase I trial outcomes in older patients with advanced solid tumours
    K H Khan
    T A Yap
    A Ring
    L R Molife
    S Bodla
    K Thomas
    A Zivi
    A Smith
    I Judson
    U Banerji
    J S de Bono
    S B Kaye
    British Journal of Cancer, 2016, 114 : 262 - 268
  • [10] Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial
    Arslan, Shukaib
    Marconi, Giovanni
    Martinelli, Giovanni
    Fleming, Shaun
    Curti, Antonio
    Dinner, Shira N.
    Blachly, James S.
    Della Porta, Matteo Giovanni
    Bajel, Ashish
    Sauer, Tim
    Crysandt, Martina
    Pigneux, Arnaud
    Fransecky, Lars
    Baldus, Claudia D.
    Konopleva, Marina Y.
    Marmor, Yotvat
    Sharma, Shringi
    Elgeioushi, Nairouz
    Cheung, Patricia
    Rowe, Emily
    Jahn, Ekaterina
    Yu, Ting
    Saeh, Jamal
    Tibes, Raoul
    Cader, Fathima Zumla
    Jain, Nitin
    BLOOD, 2023, 142
12345